Drug Profile
KX 5
Latest Information Update: 26 May 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 26 May 2001 Profile reviewed but no significant changes made
- 26 Mar 1998 No-Development-Reported for Transplant rejection in Australia (Unknown route)
- 26 Mar 1998 No-Development-Reported for Transplant rejection in Japan (Unknown route)